LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

December 31, 2011

Conditions
AtherosclerosisVascular DiseaseArteriosclerosis
Interventions
DEVICE

Lutonix Catheter

Paclitaxel Coated Balloon Catheter

DEVICE

Standard uncoated Balloon Angioplasty Catheter

plain, uncoated angioplasty balloon catheter

Trial Locations (10)

Unknown

Sint Blasius, Dendermonde

Herz Zentrum, Bad Krozingen

Jewish Hospital, Berlin

St Katharenen Cardiovascular Center, Frankfurt

Hamburg Unversity Cardiovascular Center, Hamburg

Park Krankenhaus - University of Leipzig, Leipzig

Universitätsklinikum, Magdeburg

St. Franziskus, Münster

Klinikum Rosenheim, Rosenheim

Katharinenhospital, Stuttgart

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT00930813 - LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis | Biotech Hunter | Biotech Hunter